A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis

Geranylgeranoic acid (GGA) was developed as a preventative agent against second primary hepatoma, and was reported to induce cell death in human hepatoma cells via Toll-like receptor 4 (TLR4)-mediated pyroptosis. We recently reported that GGA is enzymatically biosynthesized from mevalonic acid in hu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yoshihiro Shidoji, Chieko Iwao
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/8a06228665d040708fb63c306070df80
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8a06228665d040708fb63c306070df80
record_format dspace
spelling oai:doaj.org-article:8a06228665d040708fb63c306070df802021-11-26T04:35:24ZA rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis2405-580810.1016/j.bbrep.2021.101176https://doaj.org/article/8a06228665d040708fb63c306070df802021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2405580821002703https://doaj.org/toc/2405-5808Geranylgeranoic acid (GGA) was developed as a preventative agent against second primary hepatoma, and was reported to induce cell death in human hepatoma cells via Toll-like receptor 4 (TLR4)-mediated pyroptosis. We recently reported that GGA is enzymatically biosynthesized from mevalonic acid in human hepatoma-derived HuH-7 cells and that endogenous GGA is found in most rat organs including the liver. An unbiased metabolomics analysis of ice-cold 50% acetonitrile extracts from control and GGA-treated cells was performed in this study to characterize the intracellular metabolic changes in GGA-induced pyroptosis and to analyze their relationship with the mechanism of GGA-induced cell death. The total positive ion chromatograms of the cellular extracts in ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry were apparently unchanged after GGA treatment, but an orthogonal partial least squares-discriminant analysis score plot clearly discriminated the intracellular metabolite profiles of GGA-treated cells from that of control cells. S-plot analysis revealed 15 potential biomarkers up-regulated by 24-h GGA treatment according to their variable importance in the projection value of more than 1, and the subsequent metabolomics analysis identified nine of these metabolites as a group of lysophospholipids containing lysophosphatidylcholine with C16:0, C20:4, or C20:3 fatty acids. The possible roles of these lysophospholipids in GGA-induced pyroptosis are discussed.Yoshihiro ShidojiChieko IwaoElsevierarticleGeranylgeranoic acidLysophospholipidsHepatomaMetabolomicsCell deathBiology (General)QH301-705.5BiochemistryQD415-436ENBiochemistry and Biophysics Reports, Vol 28, Iss , Pp 101176- (2021)
institution DOAJ
collection DOAJ
language EN
topic Geranylgeranoic acid
Lysophospholipids
Hepatoma
Metabolomics
Cell death
Biology (General)
QH301-705.5
Biochemistry
QD415-436
spellingShingle Geranylgeranoic acid
Lysophospholipids
Hepatoma
Metabolomics
Cell death
Biology (General)
QH301-705.5
Biochemistry
QD415-436
Yoshihiro Shidoji
Chieko Iwao
A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
description Geranylgeranoic acid (GGA) was developed as a preventative agent against second primary hepatoma, and was reported to induce cell death in human hepatoma cells via Toll-like receptor 4 (TLR4)-mediated pyroptosis. We recently reported that GGA is enzymatically biosynthesized from mevalonic acid in human hepatoma-derived HuH-7 cells and that endogenous GGA is found in most rat organs including the liver. An unbiased metabolomics analysis of ice-cold 50% acetonitrile extracts from control and GGA-treated cells was performed in this study to characterize the intracellular metabolic changes in GGA-induced pyroptosis and to analyze their relationship with the mechanism of GGA-induced cell death. The total positive ion chromatograms of the cellular extracts in ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry were apparently unchanged after GGA treatment, but an orthogonal partial least squares-discriminant analysis score plot clearly discriminated the intracellular metabolite profiles of GGA-treated cells from that of control cells. S-plot analysis revealed 15 potential biomarkers up-regulated by 24-h GGA treatment according to their variable importance in the projection value of more than 1, and the subsequent metabolomics analysis identified nine of these metabolites as a group of lysophospholipids containing lysophosphatidylcholine with C16:0, C20:4, or C20:3 fatty acids. The possible roles of these lysophospholipids in GGA-induced pyroptosis are discussed.
format article
author Yoshihiro Shidoji
Chieko Iwao
author_facet Yoshihiro Shidoji
Chieko Iwao
author_sort Yoshihiro Shidoji
title A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
title_short A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
title_full A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
title_fullStr A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
title_full_unstemmed A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
title_sort rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived huh-7 cells revealed by metabolomics analysis
publisher Elsevier
publishDate 2021
url https://doaj.org/article/8a06228665d040708fb63c306070df80
work_keys_str_mv AT yoshihiroshidoji arapidincreaseinlysophospholipidsaftergeranylgeranoicacidtreatmentinhumanhepatomaderivedhuh7cellsrevealedbymetabolomicsanalysis
AT chiekoiwao arapidincreaseinlysophospholipidsaftergeranylgeranoicacidtreatmentinhumanhepatomaderivedhuh7cellsrevealedbymetabolomicsanalysis
AT yoshihiroshidoji rapidincreaseinlysophospholipidsaftergeranylgeranoicacidtreatmentinhumanhepatomaderivedhuh7cellsrevealedbymetabolomicsanalysis
AT chiekoiwao rapidincreaseinlysophospholipidsaftergeranylgeranoicacidtreatmentinhumanhepatomaderivedhuh7cellsrevealedbymetabolomicsanalysis
_version_ 1718409853282549760